Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which ...

The PIONEER TEENS trial compared oral semaglutide at maximum tolerated doses with placebo in adolescents aged 10 to 17 years with T2D.

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug ...

A cannabis industry group calls President Donald Trump’s reclassification of state-licensed medical marijuana as a ...

Novo Nordisk A/S NVO reported positive topline results from its late-stage PIONEER TEENS trial, showing that oral semaglutide ...

Acting Attorney General Todd Blanche signed an order under President Trump’s direction on Thursday to reclassify ...

President Trump's move reclassifies medical marijuana as a Schedule III drug. Discover what types of drugs marijuana is now classified with. (AP Photo) ...

Oral semaglutide lowered HbA1c vs placebo in a phase 3 trial in adolescents with type 2 diabetes, pending full data and ...

Novo Nordisk (NVO) stock gains after oral semaglutide pill succeeds in pediatric type 2 diabetes trial. Company targets H2 ...

A MAN who repeatedly told a doctor he feared he was suffering a life-threatening diabetes complication died just days later ...

Novo Nordisk’s oral GLP-1 therapy significantly lowered blood sugar in children and adolescents with type 2 diabetes in a late-stage trial, marking the first study of this drug class in the age group.